Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Argus Health
Cantor Fitzgerald
Chubb
Queensland Health
Covington
US Army
US Department of Justice
Deloitte

Generated: May 26, 2018

DrugPatentWatch Database Preview

PRESAMINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Presamine, and when can generic versions of Presamine launch?

Presamine is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in PRESAMINE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
Summary for PRESAMINE
Drug patent expirations by year for PRESAMINE
Synonyms for PRESAMINE
(3-(10H,11H-dibenzo[b,f]azepin-5-yl)propyl)dimethylamine, chloride
(3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}propyl)dimethylamine hydrochloride
(3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)dimethylamine hydrochloride
(3-{2-AZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3,5,7,11,13-HEXAEN-2-YL}PROPYL)DIMETHYLAMINE HYDROCHLORIDE
10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine hydrochloride
10,11-Dihydro-N,N-dimethyl- dibenz[b,f]azepine-5- propanamine
10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine hydrochloride
10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine hydrochloride; 5-[3-(Dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine hydrochloride
10,11-Dihydro-N,N-dimethyl-5H-dibenzo[b,f]azepine-5-propanamine Hydrochloride
10,11-Dihydro-N,N-dimethyl-dibenz[b,f]azepine-5-propanamine hydrochloride
10,11-dihydro-n,n-dimithyl-5,h-dibenz[b,f]azepine-5-propanamine
113-52-0
113I520
3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine hydrochloride
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine hydrochloride
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine;hydrochloride
5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine monohydrochloride
5-(3-Dimethylaminopropyl)-10,11-dihydro-5h-dibenz-[b,f]-azepine, hydrochloride
5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenz(b,f)azepine hydrochloride
5-(3-dimethylaminopropyl)-10,11-dihydro-5h-dibenz(b,f)azepinehydrochloride
5-(3-dimethylaminopropyl)-10,f)azepine hydrochloride
5-[3-(Dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine hydrochloride
5-[3-(Dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[b,f]azepine Hydrochloride
50-49-7 (Parent)
5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-, hydrochloride (1:1)
5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-, monohydrochloride
5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)propyl)-, hydrochloride
5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-, monohydrochloride
5H-Dibenz[b, 10,11-dihydro-5-[3-(dimethylamino)propyl]-, hydrochloride
5H-Dibenz[b, 10,11-dihydro-N,N-dimethyl-, monohydrochloride
5H-Dibenz[b, 5-[3-(dimethylamino)propyl]-10,11-dihydro-, monohydrochloride
5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-, hydrochloride (1:1)
5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-, monohydrochloride
5h-dibenz[b,f]azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-,monohydrochloride
AB1009320
AC-7587
AC1L1QJV
AC1Q3BL7
AK175066
AKOS015895330
AN-8868
Antideprin hydrochloride
antideprinhydrochloride
API0002985
BC210152
BG0219
BKE5Q1J60U
C07982
C19H24N2.HCl
CAS-113-52-0
CC-29494
CCG-40208
CHEBI:5882
CHEMBL1692
Chimoreptin
Chrytemin
Co cap imipramine 25
cocapimipramine25
CPD000058388
CS-6180
CTK8E8407
D00815
Deprinol
DSSTox_CID_20738
DSSTox_GSID_40738
DSSTox_RID_79581
DTXSID7040738
Dynazina
Efuranol
EINECS 204-030-7
EU-0100702
Feinalmin
FT-0631652
Fujisawa
G 22150
G 22355
HMS1568O05
HMS1920F17
HY-B1490
I 7379
I06-0739
I0971
IA-Pram
Imidol
Imilanyle
Imipram
Imipramine (hydrochloride)
Imipramine for system suitability, European Pharmacopoeia (EP) Reference Standard
Imipramine Hcl
Imipramine hydrochloride
Imipramine hydrochloride (JP17/USP)
Imipramine hydrochloride [JAN]
Imipramine hydrochloride [USP:JAN]
Imipramine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Imipramine hydrochloride, >=99% (TLC)
Imipramine hydrochloride, BioXtra, >=99% (TLC)
Imipramine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Imipramine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Imipramine hydrochloride, Sigma Reference Standard
Imipramine hydrochloride, United States Pharmacopeia (USP) Reference Standard
imipramine hydrochloride,berkomine,deprinol,dyna-zina,imiprin,iramil
Imipramine monohydrochloride
Imipramine, Hydrochloride
Imipramine(hydrochloride)
ImipramineHCl
Imipramini
Imipramini hydrochloridum
Imizin
IMP hydrochloride
Iprogen
J-002975
KS-00001FC4
KS-00002WV4
KS-1072
LP00702
LS-60471
M569
MCULE-5997199711
Melipramine HCl
Melipramine hydrochloride
MFCD00012669
MLS000028430
MLS001146891
MLS002222195
MolPort-003-666-208
N-(.gamma.-Dimethylaminopropyl)iminodibenzyl hydrochloride
N-(3-Dimethylaminopropyl)iminodibenzyl hydrochloride
N-(gamma-Dimethylaminopropyl)iminodibenzyl hydrochloride
N-(gamma-Dimetilaminopropil)-iminodibenzile cloridrato
N-(gamma-Dimetilaminopropil)-iminodibenzile cloridrato [Italian]
NC00570
NCGC00024253-05
NCGC00094054-01
NCGC00094054-02
NCGC00094054-03
NCGC00094054-04
NCGC00094054-05
NCGC00255651-01
NCGC00261387-01
NSC 114900
NSC-114900
NSC-757074
NSC114900
NSC757074
Odeoxil
Opera_ID_319
Persamine
Pertofram
Pharmakon1600-01500348
PL005935
Prestwick_277
Pryleugan
Psicopramine
Q-200878
REGID_for_CID_8228
SAM002564216
SBB057673
SCHEMBL41765
SK-Pramine HCl
SK-Pramine hydrochloride
SMR000058388
SPECTRUM1500348
SR-01000003064
SR-01000003064-2
SureCN41766
Teperine
Thymopramin
Tipramine
Tofranil
Tofranil (TN)
Tofranile
Tox21_301417
Tox21_500702
TR-002613
UNII-BKE5Q1J60U
Venefon
Vionyl
WLN: T C676 BN & T & J B3N1 & 1 & GH
XZZXIYZZBJDEEP-UHFFFAOYSA-N
Z1551429721

US Patents and Regulatory Information for PRESAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us PRESAMINE imipramine hydrochloride TABLET;ORAL 011836-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PRESAMINE imipramine hydrochloride TABLET;ORAL 011836-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PRESAMINE imipramine hydrochloride TABLET;ORAL 011836-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Colorcon
Mallinckrodt
Chinese Patent Office
Daiichi Sankyo
Covington
Medtronic
Accenture
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.